Report Australia and Oceania - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Apr 1, 2023

Australia and Oceania - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)

Australia and Oceania: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in Australia and Oceania

The medicaments containing insulin market in Australia and Oceania skyrocketed to $X in 2021, with an increase of 27% against the previous year. Overall, consumption, however, recorded a relatively flat trend pattern. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in Australia and Oceania

In value terms, medicaments containing insulin production reduced to $X in 2021 estimated in export price. Over the period under review, production, however, saw a pronounced setback. The pace of growth was the most pronounced in 2020 with an increase of 3%. The level of production peaked at $X in 2012; however, from 2013 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports in Australia and Oceania

In 2021, medicaments containing insulin exports in Australia and Oceania skyrocketed to X tons, picking up by 174% against 2020. Overall, exports saw a significant expansion. The pace of growth was the most pronounced in 2014 when exports increased by 210% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2016; however, from 2017 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing insulin exports surged to $X in 2021. In general, exports recorded a strong increase. The pace of growth was the most pronounced in 2015 when exports increased by 179%. The level of export peaked at $X in 2016; however, from 2017 to 2021, the exports failed to regain momentum.

Exports by Country

Australia dominates exports structure, accounting for X tons, which was near 97% of total exports in 2021. New Zealand (X kg) followed a long way behind the leaders.

Australia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of +42.5% from 2012 to 2021. New Zealand (-12.3%) illustrated a downward trend over the same period. While the share of Australia (+97 p.p.) increased significantly in terms of the total exports from 2012-2021, the share of New Zealand (-96.6 p.p.) displayed negative dynamics.

In value terms, Australia ($X) remains the largest medicaments containing insulin supplier in Australia and Oceania, comprising 99% of total exports. The second position in the ranking was held by New Zealand ($X), with a 0.8% share of total exports.

From 2012 to 2021, the average annual growth rate of value in Australia totaled +42.1%.

Export Prices by Country

The export price in Australia and Oceania stood at $X per ton in 2021, shrinking by -20.8% against the previous year. In general, the export price recorded a drastic downturn. The most prominent rate of growth was recorded in 2019 an increase of 67% against the previous year. The level of export peaked at $X per ton in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Australia ($X per ton), while New Zealand stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Australia (-0.3%).

Medicaments Containing Insulin Imports

Imports in Australia and Oceania

In 2021, the amount of medicaments containing insulin but not antibiotics imported in Australia and Oceania soared to X tons, picking up by 77% compared with the previous year's figure. Over the period under review, imports, however, continue to indicate a relatively flat trend pattern. The volume of import peaked at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2021. In general, imports enjoyed a buoyant expansion. As a result, imports reached the peak and are likely to continue growth in the immediate term.

Imports by Country

The purchases of the six major importers of medicaments containing insulin but not antibiotics, namely New Caledonia, Australia, Samoa, Tonga, Fiji and Solomon Islands, represented more than two-thirds of total import. Vanuatu (X kg) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were recorded for Samoa (with a CAGR of +52.2%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, New Caledonia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Australia and Oceania, comprising 48% of total imports. The second position in the ranking was held by Australia ($X), with a 15% share of total imports. It was followed by Fiji, with a 12% share.

In New Caledonia, medicaments containing insulin imports expanded at an average annual rate of +8.2% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Australia (+51.5% per year) and Fiji (-0.1% per year).

Import Prices by Country

The import price in Australia and Oceania stood at $X per ton in 2021, picking up by 31% against the previous year. Import price indicated a prominent increase from 2012 to 2021: its price increased at an average annual rate of +9.0% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2014 an increase of 75%. Over the period under review, import prices reached the peak figure in 2021 and is likely to continue growth in the immediate term.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was New Caledonia ($X per ton), while Vanuatu ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Samoa (+32.3%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform

Base Year Historical Period Forecast Period Units
2022 2012-2022 2023-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in Australia and Oceania?
+
The country with the largest volume of medicaments containing insulin consumption was New Zealand, comprising approx. 59% of total volume. Moreover, medicaments containing insulin consumption in New Zealand exceeded the figures recorded by the second-largest consumer, New Caledonia, fivefold. The third position in this ranking was taken by Samoa, with a 7.4% share.
What are the largest producers of medicaments containing insulin but not antibiotics in Australia and Oceania?
+
The country with the largest volume of medicaments containing insulin production was New Zealand, comprising approx. 74% of total volume. Moreover, medicaments containing insulin production in New Zealand exceeded the figures recorded by the second-largest producer, Australia, threefold.
What are the leading suppliers of medicaments containing insulin but not antibiotics in Australia and Oceania?
+
In value terms, Australia remains the largest medicaments containing insulin supplier in Australia and Oceania, comprising 99% of total exports. The second position in the ranking was held by New Zealand, with a 0.8% share of total exports.
What are the leading importers of medicaments containing insulin but not antibiotics in Australia and Oceania?
+
In value terms, New Caledonia constitutes the largest market for imported medicaments containing insulin but not antibiotics in Australia and Oceania, comprising 48% of total imports. The second position in the ranking was held by Australia, with a 15% share of total imports. It was followed by Fiji, with a 12% share.
What is the average export price for medicaments containing insulin but not antibiotics in Australia and Oceania?
+
The export price in Australia and Oceania stood at $108,875 per ton in 2021, with a decrease of -20.8% against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in Australia and Oceania?
+
The import price in Australia and Oceania stood at $246,987 per ton in 2021, with an increase of 31% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Australia and Oceania. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
• American Samoa
• Cook Islands
• Fiji
• French Polynesia
• Guam
• Kiribati
• Marshall Islands
• Micronesia
• Nauru
• New Caledonia
• Niue
• Northern Mariana Islands
• Palau
• Papua New Guinea
• Samoa
• Solomon Islands
• Tokelau
• Tonga
• Tuvalu
• Vanuatu
• Wallis and Futuna Islands

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Production in Australia and Oceania, split by region and country
• Trade (exports and imports) in Australia and Oceania
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
REPORT DESCRIPTION
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
CONSUMPTION BY COUNTRY
3.3
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
7.2
PRODUCTION BY COUNTRY
8. IMPORTS

The Largest Importers on The Market and How They Succeed

8.1
IMPORTS FROM 2012–2022
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Exporters on The Market and How They Succeed

9.1
EXPORTS FROM 2012–2022
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

11. COUNTRY PROFILES

The Largest Markets And Their Profiles

• Australia
• Cook Islands
• Fiji
• French Polynesia
• Kiribati
• Marshall Islands
• Micronesia
• New Caledonia
• New Zealand
• Northern Mariana Islands
• Palau
• Papua New Guinea
• Samoa
• Solomon Islands
• Tokelau
• Tonga
• Tuvalu
• Vanuatu
• Wallis and Futuna Islands
• American Samoa
• Nauru
• Niue
• Guam
LIST OF TABLES
Table 1:
Key Findings In 2022
Table 2:
Market Volume, In Physical Terms, 2012–2022
Table 3:
Market Value, 2012–2022
Table 4:
Per Capita Consumption, By Country, 2018–2022
Table 5:
Production, In Physical Terms, By Country, 2012–2022
Table 6:
Imports, In Physical Terms, By Country, 2012–2022
Table 7:
Imports, In Value Terms, By Country, 2012–2022
Table 8:
Import Prices, By Country Of Destination, 2012–2022
Table 9:
Exports, In Physical Terms, By Country, 2012–2022
Table 10:
Exports, In Value Terms, By Country, 2012–2022
Table 11:
Export Prices, By Country Of Origin, 2012–2022
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2022
Figure 2:
Market Value, 2012–2022
Figure 3:
Consumption, By Country, 2022
Figure 4:
Market Forecast To 2030
Figure 5:
Products: Market Size And Growth, By Type
Figure 6:
Products: Average Per Capita Consumption, By Type
Figure 7:
Products: Exports And Growth, By Type
Figure 8:
Products: Export Prices And Growth, By Type
Figure 9:
Production Volume And Growth
Figure 10:
Exports And Growth
Figure 11:
Export Prices And Growth
Figure 12:
Market Size And Growth
Figure 13:
Per Capita Consumption
Figure 14:
Imports And Growth
Figure 15:
Import Prices
Figure 16:
Production, In Physical Terms, 2012–2022
Figure 17:
Production, In Value Terms, 2012–2022
Figure 18:
Production, By Country, 2022
Figure 19:
Production, In Physical Terms, By Country, 2012–2022
Figure 20:
Imports, In Physical Terms, 2012–2022
Figure 21:
Imports, In Value Terms, 2012–2022
Figure 22:
Imports, In Physical Terms, By Country, 2022
Figure 23:
Imports, In Physical Terms, By Country, 2012–2022
Figure 24:
Imports, In Value Terms, By Country, 2012–2022
Figure 25:
Import Prices, By Country, 2012–2022
Figure 26:
Exports, In Physical Terms, 2012–2022
Figure 27:
Exports, In Value Terms, 2012–2022
Figure 28:
Exports, In Physical Terms, By Country, 2022
Figure 29:
Exports, In Physical Terms, By Country, 2012–2022
Figure 30:
Exports, In Value Terms, By Country, 2012–2022
Figure 31:
Export Prices, 2012–2022
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET